KRYS · Company research
Krystal Biotech, Inc. (KRYS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) Stock Forecasts - Yahoo Finance | Krystal Biotech, Inc. (KRYS) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 17, 2026 | neutral | 0 | 0.6 |
| KRYS Reports Positive Early Data for KB113 in Gorlin Syndrome | Krystal Biotech announced positive pilot study results for KB113, an investigational immunotherapy for basal cell carcinomas in Gorlin syndrome patients. The treatment showed clinical regression in 83.1% of assessed lesions across three patients, including 85.1% regression in non-injected lesions suggesting systemic immune activity. KB113 was well tolerated, and the company has begun FDA discussions on advanced clinical development. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | bullish | 1 | 1 |
| Krystal Biotech (KRYS) Posts Strong KB113 Data, Is The Stock Fully Priced? - Simply Wall Street | Krystal Biotech (KRYS) Posts Strong KB113 Data, Is The Stock Fully Priced? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 16, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech, Inc. (KRYS) Stock Price, News, Quote & History - Yahoo! Finance Canada | Krystal Biotech, Inc. (KRYS) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech, Inc. (KRYS) Stock forecasts - Yahoo Finance UK | Krystal Biotech, Inc. (KRYS) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| An experimental skin cancer treatment shrank some tumors doctors didn't inject. Three patients were studied. - Stock Titan | An experimental skin cancer treatment shrank some tumors doctors didn't inject. Three patients were studied. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech, Inc. (KRYS) Stock forecasts - Yahoo Finance UK | Krystal Biotech, Inc. (KRYS) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 10, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech: My Analysis Suggests Stock Has Not Yet Reached Peak Value (NASDAQ:KRYS) - Seeking Alpha | Krystal Biotech: My Analysis Suggests Stock Has Not Yet Reached Peak Value (NASDAQ:KRYS) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 10, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech (NasdaqGS:KRYS) Stock Price - Simply Wall Street | Krystal Biotech (NasdaqGS:KRYS) Stock Price Simply Wall Street | View source ↗ | Simply Wall Street | Oct 8, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech (KRYS) Stock Looks Overvalued After A 7x Run - Yahoo Finance UK | Krystal Biotech (KRYS) Stock Looks Overvalued After A 7x Run Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 8, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech, Inc. (KRYS) Stock Forecasts - Yahoo Finance | Krystal Biotech, Inc. (KRYS) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits | KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism Stocktwits | View source ↗ | Stocktwits | Oct 5, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech (KRYS) Stock Looks Stretched Against Current Earnings Power - Simply Wall Street | Krystal Biotech (KRYS) Stock Looks Stretched Against Current Earnings Power Simply Wall Street | View source ↗ | Simply Wall Street | Sep 25, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech (NasdaqGS:KRYS) Stock Forecast & Analyst Predictions - Simply Wall Street | Krystal Biotech (NasdaqGS:KRYS) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 24, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech (KRYS) board member receives new options and RSUs - Stock Titan | Krystal Biotech (KRYS) board member receives new options and RSUs Stock Titan | View source ↗ | Stock Titan | Sep 16, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run - Yahoo Finance | Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run Yahoo Finance | View source ↗ | Yahoo Finance | Aug 10, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech Q2 revenue rises to $119.2 million on VYJUVEK sales | KRYS Stock News - Quiver Quantitative | Krystal Biotech Q2 revenue rises to $119.2 million on VYJUVEK sales | KRYS Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 3, 2026 | neutral | 0 | 0.6 |
| Krystal Biotech (KRYS) Stock Price Drops As Premium Expectations Reset - Simply Wall Street | Krystal Biotech (KRYS) Stock Price Drops As Premium Expectations Reset Simply Wall Street | View source ↗ | Simply Wall Street | Aug 3, 2026 | neutral | 0 | 0.6 |
| Is Krystal Biotech, Inc. (KRYS) A Good Stock To Buy Now? - Yahoo Finance | Is Krystal Biotech, Inc. (KRYS) A Good Stock To Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 7, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.